From: Gastrointestinal manifestations of synthetic cannabinoids: a retrospective cohort study
Measure (mean ± SD) | With GI symptoms | Without GI symptoms | p value |
---|---|---|---|
Temperature | 36.5 ± 0.6 | 36.6 ± 0.5 | 0.50 |
Heart rate | 72.9 ± 20.8 | 79.3 ± 17.3 | 0.26 |
Systolic BP | 131 ± 18.6 | 134.2 ± 18.5 | 0.84 |
WBC | 17.2 ± 8.3 | 14.0 ± 5.6 | 0.09 |
HGB | 16.3 ± 1.3 | 15.6 ± 1.7 | 0.19 |
ALT | 22.2 ± 14.5 | 41.0 ± 68.9 | 0.30 |
ALK PHOS | 81.9 ± 24.0 | 91.8 ± 36.8 | 0.37 |
pH | 7.4 ± 0.1 | 7.3 ± 0.2 | 0.19 |
Lactate | 4.3 ± 4.9 | 4.5 ± 4.4 | 0.92 |
Creatinine mmol/Liter | 104.8 ± 60.3 | 85.1 ± 26.0 | 0.24 |
Potassium mEq/Liter | 3.7 ± 0.8 | 3.8 ± 0.5 | 0.50 |